AdaptHealth Q4 revenue beats expectations, loss bigger than expected

Adapthealth

24/02/2026 12:14

Overview

Healthcare-at-home provider's Q4 revenue beat analyst expectations

Q4 operating loss and pretax loss wider than analyst expectations

Company expanded footprint by acquiring HME provider in Hawaii

Outlook

AdaptHealth forecasts 2026 net revenue between $3.44 bln and $3.51 bln

Company expects 2026 adjusted EBITDA of $680 mln to $730 mln

AdaptHealth projects 2026 free cash flow of $175 mln to $225 mln

Result Drivers

PATIENT GROWTH - AdaptHealth set new patient census records in Sleep Health, Respiratory Health, and Wellness at Home

GEOGRAPHIC EXPANSION - Acquired a leading HME provider in Hawaii, expanding the company's footprint to its 48th state

DIGITAL ENGAGEMENT - More than doubled myApp users to 327,300, enhancing digital patient engagement

Company press release: ID:nBw8nk0Wma

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Beat
$846.29 mln
$831.61 mln (8 Analysts)
Q4 Net Income
-$101.54 mln
Q4 Operating Income
Miss
-$73.28 mln
$89.60 mln (8 Analysts)
Q4 Pretax Profit
Miss
-$97.99 mln
$65.06 mln (7 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for Adapthealth Corp is $13.00, about 26.3% above its February 23 closing price of $10.29

The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 8 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)